Rinat Eshel
Impact in
-
- CAR-T cell therapy research
- Cancer Cells and Metastasis
-
- Cell Adhesion Molecules Research
Papers in
-
- Glycosylation and Glycoproteins Research 8
- Oncology 7
- CAR-T cell therapy research 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Orit Sagi‐Assif (7 shared papers)Isaac P. Witz (6 shared papers)Ben‐Zion Katz (4 shared papers)Guus A.M.S. van Dongen (2 shared papers)Ruud H. Brakenhoff (2 shared papers)Tal Freund (2 shared papers)Yael Bar‐On (2 shared papers)Sigi Kay (2 shared papers)
- Journals
- International Journal of Cancer (3 papers)Pediatric Transplantation (2 papers)Seminars in Cancer Biology (1 paper)International Journal of Oncology (1 paper)Cellular Immunology (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Rinat Eshel
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 50
- Oncology 147
- Immunology and Allergy 31
- Infectious Diseases 79
- Immunology 87
- Hematology 40
Countries citing papers authored by Rinat Eshel
This map shows the geographic impact of Rinat Eshel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Eshel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Eshel more than expected).
Fields of papers citing papers by Rinat Eshel
This network shows the impact of papers produced by Rinat Eshel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Eshel. The network helps show where Rinat Eshel may publish in the future.
Co-authors
The 25 scholars most cited alongside Rinat Eshel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 94 | |
| 2 | 2002 | 37 | |
| 3 | 1998 | 36 | |
| 4 | 1994 | 32 | |
| 5 | 2000 | 28 | |
| 6 | 2020 | 27 | |
| 7 | 2001 | 13 | |
| 8 | 2006 | 10 | |
| 9 | 2002 | 9 | |
| 10 | 1995 | 7 | |
| 11 | 2016 | 7 | |
| 12 | 2003 | 6 | |
| 13 | 2005 | 6 | |
| 14 | JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts. | 2013 | 5 |
| 15 | 2004 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 1997 | 1 | |
| 19 | 2017 | 0 |
About Rinat Eshel
Rinat Eshel is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Immunology and Allergy, having authored 19 papers that have together received 325 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Cell Adhesion Molecules Research (5 papers), Galectins and Cancer Biology (4 papers), CAR-T cell therapy research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Immunotherapy and Immune Responses (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (147 citations), Immunology and Allergy (31 citations), Infectious Diseases (79 citations), Immunology (87 citations) and Hematology (40 citations). Rinat Eshel has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Orit Sagi‐Assif, Isaac P. Witz, Ben‐Zion Katz, Guus A.M.S. van Dongen, Ruud H. Brakenhoff, Tal Freund, Yael Bar‐On, Sigi Kay, Chava Perry and Odelia Amit. Their work appears in journals such as International Journal of Cancer, Pediatric Transplantation, Seminars in Cancer Biology, International Journal of Oncology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.